No Data
Verona Pharma Announces December 2024 Investor Conference Participation
Verona Pharma Plc's (NASDAQ:VRNA) Path To Profitability
Druckenmiller's Duquesne Closes Some Media Holdings, Loads Into Regional Banks, Among Q3 Trades
Truist Financial Maintains Verona Pharma(VRNA.US) With Buy Rating
Form 144 | Verona Pharma(VRNA.US) Officer Proposes to Sell 4.82 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 12, $Verona Pharma(VRNA.US)$ Officer MARK HAHN intends to sell 125K shares of its common stock on Nov 11, with a total market value of approximately $4.82 million.
Form 144 | Verona Pharma(VRNA.US) Director Proposes to Sell 4.82 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 12, $Verona Pharma(VRNA.US)$ Director DAVID ZACCARDELLI intends to sell 125K shares of its common stock on Nov 11, with a total market value of approximately $4.82 million.
loading...
loading...